diabetes
A quarter of English COVID-19 deaths in hospitals were diabetics
May 15, 2020Medical Communications COVID-19, coronavirus, diabetes
The NHS’s first data breakdown of underlying health conditions in COVID-19 fatalities has shown that 1 in 4 deaths in …
Governor of Minnesota signs emergency bill for insulin access
April 17, 2020Medical Communications diabetes, insulin, insulin copays, medical insurance
Minnesota Governor Tim Walz has signed legislation to provide a one-time, 30-day supply of insulin for eligible residents in urgent …
Patient Experience: Living with type 1 diabetes
April 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience
23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …
Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19
April 8, 2020Research and Development Eli Lilly, diabetes, insulin
Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …
European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes
April 6, 2020Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma
The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …
FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes
March 23, 2020Sales and Marketing FDA, diabetes, jardiance, pharma
The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …
Fast-acting mealtime insulin approved for children with diabetes in Canada
March 10, 2020Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes
Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Type 2 diabetes drug Rosiglitazone increases risk of heart problems
February 12, 2020Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes
A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …
Type 2 diabetes cases up 40% in Scotland
February 11, 2020Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes
According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …
Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD
January 17, 2020Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma
Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …
Diabetes drug could increase stem cells in the womb to treat recurrent miscarriage
January 9, 2020Business Services Stem cells, diabetes, insulin, miscarraiges, pregnancy
A study led by the University of Warwick found that sitagliptin, a diabetes drug, could be used to treat recurrent …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
Sanofi to move away from diabetes and cardiovascular, as company shakeup continues
December 10, 2019Manufacturing and Production ASH 19, Sanofi, Sanofi Diabetes, Sanofi Insulin, diabetes, insulin
Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
